Structural diversity and mode of action on lipid membranes of three lactoferrin candidacidal peptides

Biochimica et Biophysica Acta - Biomembranes

Volumn 1828, Issue 5, 2013, Pages 1329-1339

  Silva, Tânia ^a,b   Adão, Regina ^a   Nazmi, Kamran ^c   Bolscher, Jan G M ^c   Funari, Sérgio S ^d   Uhríková, Daniela ^e   Bastos, Margarida ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d DESY   (Germany)

^e Physics and Informatics   (Slovakia)

Author keywords

Antimicrobial peptides; CD; DSC; Lactoferrin peptides; SAXD

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; HYBRID PROTEIN; LACTOFERRAMPIN [265-284] PEPTIDE; LACTOFERRICIN [17-30] PEPTIDE; LACTOFERRIN CHIMERA PEPTIDE; LIPOSOME; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; CIRCULAR DICHROISM; DIFFERENTIAL SCANNING CALORIMETRY; LIPID MEMBRANE; MEMBRANE DAMAGE; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN LIPID INTERACTION; PROTEIN SECONDARY STRUCTURE; STRUCTURE ANALYSIS; TEMPERATURE SENSITIVITY; THERMODYNAMICS; X RAY DIFFRACTION;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CANDIDA ALBICANS; CELL MEMBRANE; CIRCULAR DICHROISM; DIMYRISTOYLPHOSPHATIDYLCHOLINE; LACTOFERRIN; MEMBRANE LIPIDS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; THERMODYNAMICS; X-RAY DIFFRACTION;

EID: 84875193941     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2013.01.022     Document Type: Article

References (63)

1. V. Teixeira, M.J. Feio, and M. Bastos Role of lipids in the interaction of antimicrobial peptides with membranes Prog. Lipid Res. 51 2012 149 177
2. M.A.R.B. Castanho Membrane-active peptides: methods and results on structure and function IUL Biotechnology Series vol. 9 2010 International University Line La Jolla, CA, USA 692
3. Y. Shai, A. Makovitzky, and D. Avrahami Host defense peptides and lipopeptides: modes of action and potential candidates for the treatment of bacterial and fungal infections Curr. Protein Pept. Sci. 7 2006 479 486
4. L.T. Nguyen, E.F. Haney, and H.J. Vogel The expanding scope of antimicrobial peptide structures and their modes of action Trends Biotechnol. 29 2011 464 472
5. K.A. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3 2005 238 250
6. H.W. Huang Action of antimicrobial peptides: two-state model Biochemistry 39 2000 8347 8352
7. L. Yang, T.A. Harroun, T.M. Weiss, L. Ding, and H.W. Huang Barrel-stave model or toroidal model? A case study of melittin pores Biophys. J. 81 2001 1475 1485
8. H.H. Haukland, H. Ulvatne, K. Sandvik, and L.H. Vorland The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm FEBS Lett. 508 2001 389 393
9. H. Ulvatne, O. Samuelsen, H.H. Haukland, M. Kramer, and L.H. Vorland Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis FEMS Microbiol. Lett. 237 2004 377 384
10. J.S. Mader, A. Richardson, J. Salsman, D. Top, R. de Antueno, R. Duncan, and D.W. Hoskin Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria Exp. Cell Res. 313 2007 2634 2650
11. J.L. Gifford, H.N. Hunter, and H.J. Vogel Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties Cell. Mol. Life Sci. 62 2005 2588 2598
12. K. Lohner, and E.J. Prenner Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems Biochim. Biophys. Acta 1462 1999 141 156
13. M.K. Wassef, T.B. Fioretti, and D.M. Dwyer Lipid analyses of isolated surface membranes of Leishmania donovani promastigotes Lipids 20 1985 108 115
14. A. Singh, T. Prasad, K. Kapoor, A. Mandal, M. Roth, R. Welti, and R. Prasad Phospholipidome of Candida: each species of Candida has distinctive phospholipid molecular species OMICS 14 2010 665 677
15. V.V. Andrushchenko, H.J. Vogel, and E.J. Prenner Interactions of tryptophan-rich cathelicidin antimicrobial peptides with model membranes studied by differential scanning calorimetry Biochim. Biophys. Acta 1768 2007 2447 2458
16. J.G. Bolscher, R. Adão, K. Nazmi, P.A. van den Keybus, W. van 't Hof, A.V. Nieuw Amerongen, M. Bastos, and E.C. Veerman Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides Biochimie 91 2009 123 132
17. E.F. Haney, F. Lau, and H.J. Vogel Solution structures and model membrane interactions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin Biochim. Biophys. Acta 1768 2007 2355 2364
18. E.F. Haney, K. Nazmi, J.G. Bolscher, and H.J. Vogel Structural and biophysical characterization of an antimicrobial peptide chimera comprised of lactoferricin and lactoferrampin Biochim. Biophys. Acta 1818 2012 762 775
19. A. Hickel, S. Danner-Pongratz, H. Amenitsch, G. Degovics, M. Rappolt, K. Lohner, and G. Pabst Influence of antimicrobial peptides on the formation of nonlamellar lipid mesophases Biochim. Biophys. Acta 1778 2008 2325 2333
20. H.W. Huang Molecular mechanism of antimicrobial peptides: the origin of cooperativity Biochim. Biophys. Acta 1758 2006 1292 1302
21. W. Jing, J.S. Svendsen, and H.J. Vogel Comparison of NMR structures and model-membrane interactions of 15-residue antimicrobial peptides derived from bovine lactoferricin Biochem. Cell Biol. 84 2006 312 326
22. C.-C. Lee, Y. Sun, S. Qian, and Huey W. Huang Transmembrane pores formed by human antimicrobial peptide LL-37 Biophys. J. 100 2011 1688 1696
23. G. Pabst, D. Zweytick, R. Prassl, and K. Lohner Use of X-ray scattering to aid the design and delivery of membrane-active drugs Eur. Biophys. J. 2012 1 15
24. E.J. Prenner, R.N. Lewis, and R.N. McElhaney The interaction of the antimicrobial peptide gramicidin S with lipid bilayer model and biological membranes Biochim. Biophys. Acta 1462 1999 201 221
25. E.J. Prenner, R.N. Lewis, K.C. Neuman, S.M. Gruner, L.H. Kondejewski, R.S. Hodges, and R.N. McElhaney Nonlamellar phases induced by the interaction of gramicidin S with lipid bilayers. A possible relationship to membrane-disrupting activity Biochemistry 36 1997 7906 7916
26. E. Staudegger, E.J. Prenner, M. Kriechbaum, G. Degovics, R.N. Lewis, R.N. McElhaney, and K. Lohner X-ray studies on the interaction of the antimicrobial peptide gramicidin S with microbial lipid extracts: evidence for cubic phase formation Biochim. Biophys. Acta 1468 2000 213 230
27. D. Zweytick, S. Tumer, S.E. Blondelle, and K. Lohner Membrane curvature stress and antibacterial activity of lactoferricin derivatives Biochem. Biophys. Res. Commun. 369 2008 395 400
28. E.F. Haney, S. Nathoo, H.J. Vogel, and E.J. Prenner Induction of non-lamellar lipid phases by antimicrobial peptides: a potential link to mode of action Chem. Phys. Lipids 163 2010 82 93
29. J. Erbes, C. Czeslik, W. Hahn, R. Winter, M. Rappolt, and G. Rapp On the existence of bicontinuous cubic phases in dioleoylphosphatidylethanolamine Ber. Bunsenges. Phys. Chem. 98 1994 1287 1293
30. G. Tresset The multiple faces of self-assembled lipidic systems PMC Biophys. 2 2009 3
31. Z.A. Almsherqi, T. Landh, S.D. Kohlwein, and Y. Deng Chapter 6: cubic membranes the missing dimension of cell membrane organization Int. Rev. Cell Mol. Biol. 274 2009 275 342
32. V. Luzzati Biological significance of lipid polymorphism: the cubic phases Curr. Opin. Struct. Biol. 7 1997 661 668
33. K. Lohner New strategies for novel antibiotics: peptides targeting bacterial cell membranes Gen. Physiol. Biophys. 28 2009 105 116
34. K. Lohner, and S.E. Blondelle Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics Comb. Chem. High Throughput Screen. 8 2005 241 256
35. S.L. Keller, S.M. Gruner, and K. Gawrisch Small concentrations of alamethicin induce a cubic phase in bulk phosphatidylethanolamine mixtures Biochim. Biophys. Acta 1278 1996 241 246
36. M. Bastos, T. Silva, V. Teixeira, K. Nazmi, J.G.M. Bolscher, S.S. Funari, and D. Uhríková Lactoferrin-derived antimicrobial peptide induces a micellar cubic phase in a model membrane system Biophys. J. 101 2011 L20 L22
37. J. Bolscher, K. Nazmi, J. van Marle, W. van 't Hof, and E. Veerman Chimerization of lactoferricin and lactoferrampin peptides strongly potentiates the killing activity against Candida albicans Biochem. Cell Biol. 90 2012 378 388
38. M.I. van der Kraan, J. van Marle, K. Nazmi, J. Groenink, W. van 't Hof, E.C. Veerman, J.G. Bolscher, and A.V. Nieuw Amerongen Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli Peptides 26 2005 1537 1542
39. J.G. Bolscher, M.J. Oudhoff, K. Nazmi, J.M. Antos, C.P. Guimaraes, E. Spooner, E.F. Haney, J.J. Garcia Vallejo, H.J. Vogel, W. van't Hof, H.L. Ploegh, and E.C. Veerman Sortase A as a tool for high-yield histatin cyclization FASEB J. 25 2011 2650 2658
40. C.W.F. McClare An accurate and convenient organic phosphorous assay Anal. Biochem. 39 1971 527 530
41. F. Abrunhosa, S. Faria, P. Gomes, I. Tomaz, J.C. Pessoa, D. Andreu, and M. Bastos Interaction and lipid-induced conformation of two cecropin-melittin hybrid peptides depend on peptide and membrane composition J. Phys. Chem. B 109 2005 17311 17319
42. T.C. Huang, H. Toraya, T.N. Blanton, and Y. Wu X-ray powder diffraction analysis of silver behenate, a possible low-angle diffraction standard J. Appl. Crystallogr. 26 1993 180 184
43. N. Roveri, A. Bigi, P.P. Castellani, E. Foresti, M. Marchini, and R. Strocchi Study of rat tail tendon by X-ray diffraction and freeze-etching technics Boll. Soc. Ital. Biol. Sper. 56 1980 953 959
44. D. Chapman The polymorphism of glycerides Chem. Rev. 62 1962 433 456
45. M. Kellens, W. Meeussen, and H. Reynaers Crystallization and phase transition studies of tripalmitin Chem. Phys. Lipids 55 1990 163 178
46. LIPIDAT http://www.lipidat.tcd.ie/ (Last access on October 2012)
47. R.A. Parente, and B.R. Lentz Phase behavior of large unilamellar vesicles composed of synthetic phospholipids Biochemistry 11 1984 2353 2362
48. E.F. Haney, K. Nazmi, J.G. Bolscher, and H.J. Vogel Influence of specific amino acid side-chains on the antimicrobial activity and structure of bovine lactoferrampin Biochem. Cell Biol. 90 2012 362 377
49. H.J. Vogel, D.J. Schibli, W. Jing, E.M. Lohmeier-Vogel, R.F. Epand, and R.M. Epand Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides Biochem. Cell Biol. 80 2002 49 63
50. T. Silva, M.A. Abengozar, M. Fernandez-Reyes, D. Andreu, K. Nazmi, J.G. Bolscher, M. Bastos, and L. Rivas Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin Amino Acids 43 2012 2265 2277
51. N. Leon-Sicairos, A. Canizalez-Roman, M. de la Garza, M. Reyes-Lopez, J. Zazueta-Beltran, K. Nazmi, B. Gomez-Gil, and J.G. Bolscher Bactericidal effect of lactoferrin and lactoferrin chimera against halophilic Vibrio parahaemolyticus Biochimie 91 2009 133 140
52. P. Wadhwani, R.F. Epand, N. Heidenreich, J. Burck, A.S. Ulrich, and R.M. Epand Membrane-active peptides and the clustering of anionic lipids Biophys. J. 103 2012 265 274
53. M.I. van der Kraan, J. Groenink, K. Nazmi, E.C. Veerman, J.G. Bolscher, and A.V. Nieuw Amerongen Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin Peptides 25 2004 177 183
54. M.I. van der Kraan, K. Nazmi, A. Teeken, J. Groenink, W. van 't Hof, E.C. Veerman, J.G. Bolscher, and A.V. Nieuw Amerongen Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix-facilitating N-terminal part Biol. Chem. 386 2005 137 142
55. M.D. Strom, O. Rekdal, W. Stensen, and J.S. Svendsen Increased antibacterial activity of 15-residue murine lactoferricin derivatives J. Pept. Res. 57 2001 127 139
56. K. Lohner, and F. Prossnigg Biological activity and structural aspects of PGLa interaction with membrane mimetic systems Biochim. Biophys. Acta 1788 2009 1656 1666
57. R. Bruinsma, and J. Mashl Long-range electrostatic interaction in DNA-cationic lipid complexes Europhys. Lett. 41 1998 165 170
58. P. Mitrakos, and P.M. MacDonald DNA induced lateral segregation of cationic amphiphiles in lipid bilayer membranes as detected via 2H NMR Biochemistry 35 1996 16714 16722
59. D. Uhrikova, M. Hanulova, S.S. Funari, R.S. Khusainova, F. Sersen, and P. Balgavy The structure of DNA-DOPC aggregates formed in presence of calcium and magnesium ions: a small-angle synchrotron X-ray diffraction study Biochim. Biophys. Acta 1713 2005 15 28
60. R.N. Lewis, D.A. Mannock, and R.N. McElhaney Differential scanning calorimetry in the study of lipid phase transitions in model and biological membranes: practical considerations Methods Mol. Biol. 400 2007 171 195
61. G. Lindblom, and L. Rilfors Cubic phases and isotropic structures formed by membrane lipids - possible biological relevance Biochim. Biophys. Acta 988 1989 221 256
62. C. Oguey, and J.-F. Sadoc Crystallographic aspects of the Bonnet transformation for periodic minimal surfaces (and crystals of films) J. Phys. I France 3 1993 839 854
63. M. Hanulová Interaction of antimicrobial peptides with lipid membranes Departments Physik der Universität Hamburg, vol. PhD, Hamburg, Hamburg 2008